2nd Quarter - Report

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS

Firm
Client
Income
—
Expenses
$235,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Comprehensive Sexuality Education funding (general); National HIV/AIDS Strategy (general); Sudden Unexpected Infant Deaths (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); Gender rating (general); Stillbirth. Preventive Care (general); Domestic Violence(general); Medicaid and SCHIP Coverage and Reimbursement; HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Personal Health Record; Abortion (general); Health Care and Reconciliation Act of 2010; Health IT (general); HR 2029, S 1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); USDA Dietary Guidelines Advisory Committee Report; The Meaningful End to Defensive Medicine and Aimless Lawsuits; HR 2127, Newborn Act; Improve Maternity Care Quality; Healthy Hunger-Free Kids; HR 5, S 1099, HEALTH Act; HR 452, Medicare Decisions Accountability Act of 2011; S 668, Health Care Bureaucrats Elimination Act; HR 666, Birth Certificate Enhancement Act of 2011; HR 358, Protect Life Act; HR 894 Maternal Health Accountability Act; Imaging (general); HR 2194, S 1221, GEDI Act; HR 3, No Taxpayer Funding for Abortion Act; State Paid Leave (general); HR 2020, S 1096, Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; HR 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); HR 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; AMDT 298, Foxx Amendment; Military Access to Reproductive Care and Health for Military Women Act.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); White House Office; Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 894 (112th), H.R. 2020 (112th), H.R. 666 (112th), H.R. 1216 (112th), H.R. 2194 (112th), H.R. 3 (112th), H.R. 358 (112th), H.R. 452 (112th), H.R. 2127 (112th), H.R. 2029 (112th), H.R. 1676 (112th), H.R. 5 (112th)

Medicare/Medicaid MMM

Sustainable Growth Rate Formula Reform (general); H.R. 452, Medicare Decisions Accountability Act; S. 688, Health Care Bureaucrats Elimination Act; Imaging (general); Medicaid (general).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); White House Office; SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: H.R. 452 (112th), S. 688 (112th)

Budget/Appropriations BUD

Public health funding for National Institutes of Health (NIH), Health Resources and Services Administration (HRSA), Centers for Disease Control (CDC) and Agency for Healthcare Research and Quality (AHRQ); Comprehensive Sexuality Education funding (general); Affordable birth control; International family planning; Violence Against Women Programs; Office of Adolescent Health. Maternal Mortality Reviews; Electronic Birth and Death Records (CDC); National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment Prevention (HHS); Comparative Effectiveness Research (AHRQ); Department of Defense (DOD) Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Research (NIH); Title V Block Grant (HRSA); STD Prevention (CDC); Title X, Family Planning; FY12 Budget; Reproductive Health; Prevention; Public Health Fund; Birth Defects; National Children's Study; Medicaid and Medicare Funding.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Agency for Healthcare Research & Quality (AHRQ); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.